PIII
P3 Health Partners Inc.NASDAQHealthcare$2.52-1.95%ClosedMarket Cap: $8.2M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.05
P/S
0.01
EV/EBITDA
-0.21
DCF Value
$-400.56
FCF Yield
-1106.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.0%
Operating Margin
-18.5%
Net Margin
-10.1%
ROE
893.8%
ROA
-22.5%
ROIC
-172.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $384.8M | -122.1% | $-153.9M | $-75.5M | $-23.02 | — |
| FY 2025 | $1.46B | -9.9% | $-270.3M | $-147.9M | $-45.26 | — |
| Q3 2025 | $345.3M | -7.1% | $-44.2M | $-31.6M | $-9.67 | — |
| Q2 2025 | $355.8M | 100.0% | $-34.1M | $-20.4M | $-6.23 | — |
| Q1 2025 | $373.2M | -1.5% | $-38.1M | $-20.5M | $-6.28 | — |
| Q4 2024 | $370.7M | 100.0% | $-138.5M | $-58.6M | $-20.82 | — |
| FY 2024 | $1.50B | 100.0% | $-320.7M | $-135.8M | $-54.06 | — |
| Q3 2024 | $362.1M | 100.0% | $-107.0M | $-46.5M | $-15.70 | — |
| Q2 2024 | $379.2M | 3.7% | $-31.3M | $-12.0M | $-7.37 | — |
| Q1 2024 | $388.5M | -3.9% | $-43.8M | $-18.7M | $-7.92 | — |
| Q4 2023 | $346.9M | -12.2% | $-64.3M | $-25.5M | $-11.04 | — |
| FY 2023 | $1.27B | 100.0% | $-167.9M | $-57.8M | $-30.44 | — |